Medicare Enrolled

Dr. Danilo Del Campo, MD

Dermatology · Chicago, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
5440 W BELMONT AVE, Chicago, IL 60641
7732868111
Registered in NPPES since 2013
NPI: 1922340405 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Del Campo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Del Campo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Del Campo

Dr. Danilo Del Campo is a dermatology specialist in Chicago, IL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Del Campo performed 1,098 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Del Campo received a total of $60,542 from 40 pharmaceutical and/or device companies across 918 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Del Campo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years of NPI registration ▲ 1,098 Medicare services $60,542 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,098
Medicare services
Bottom 31% in IL for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
338 $95 $271
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
156 $5 $14
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
149 $70 $192
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
93 $1 $2
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
59 $116 $356
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
45 $48 $143
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
40 $70 $241
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
39 $11 $30
Shaving of skin growth, 1.1-2.0 cm
This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs.
35 $82 $294
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
28 $91 $242
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters.
26 $72 $262
Shaving of small skin growth on face or mouth area
A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth.
24 $58 $240
Shaving of skin growth on face, 0.6-1.0 cm
This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters.
20 $85 $294
Shaving of skin growth, 1.1-2.0 cm
Removal of a skin growth by shaving the surface. The procedure is performed on the scalp, neck, hands, feet, or genitals and involves a lesion measuring between 1.1 and 2.0 centimeters.
18 $97 $299
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
15 $80 $217
Shaving of skin growth, 1.1-2.0 cm
Removal of a skin growth by shaving the surface of the skin. The procedure is performed on the face, ears, eyelids, nose, lips, or mouth and involves a lesion measuring between 1.1 and 2.0 centimeters.
13 $113 $337
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$60,542
Total received (2018-2024)
Avg $8,649/year across 7 years
Top 7% in IL for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
918
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$21,628
2023
$4,028
2022
$5,763
2021
$23,828
2020
$1,829
2019
$1,596
2018
$1,869

Payments by company (2024)

Galderma Laboratories, L.P.
$17,661
Janssen Biotech, Inc.
$1,839
ABBVIE INC.
$356
Ortho Dermatologics, a division of Bausch Health US, LLC
$332
PFIZER INC.
$249
UCB, Inc.
$190
LEO Pharma Inc.
$183
MAYNE PHARMA COMMERCIAL LLC
$163
Amgen Inc.
$163
Novartis Pharmaceuticals Corporation
$108
REVANCE THERAPEUTICS, INC.
$86
Incyte Corporation
$78
Arcutis Biotherapeutics, Inc.
$74
Regeneron Healthcare Solutions, Inc.
$50
SUN PHARMACEUTICAL INDUSTRIES INC.
$47
GENZYME CORPORATION
$28
E.R. Squibb & Sons, L.L.C.
$20
Top 3 companies account for 91.8% of 2024 payments
All-time payments by company (2018-2024) ›
SUN PHARMACEUTICAL INDUSTRIES INC.
$20,651
Galderma Laboratories, L.P.
$17,853
EPI Health, LLC
$3,366
Janssen Biotech, Inc.
$3,066
Medimetriks Pharmaceuticals, Inc.
$2,362
LEO Pharma Inc.
$1,496
Amgen Inc.
$1,412
AbbVie Inc.
$1,268
ABBVIE INC.
$1,020
AbbVie, Inc.
$868
Ortho Dermatologics, a division of Bausch Health US, LLC
$861
PFIZER INC.
$831
Sun Pharmaceutical Industries Inc.
$801
Journey Medical Corporation
$501
Celgene Corporation
$438
Lilly USA, LLC
$357
Regeneron Healthcare Solutions, Inc.
$315
Novartis Pharmaceuticals Corporation
$304
GENZYME CORPORATION
$296
MAYNE PHARMA INC.
$289
Merz North America, Inc.
$242
Incyte Corporation
$228
UCB, Inc.
$218
Promius Pharma LLC
$170
VYNE Pharmaceuticals Inc.
$168
MAYNE PHARMA COMMERCIAL LLC
$163
Allergan Inc.
$150
Janssen Scientific Affairs, LLC
$132
PruGen, Inc. Pharmaceuticals
$121
E.R. Squibb & Sons, L.L.C.
$111
Arcutis Biotherapeutics, Inc.
$87
REVANCE THERAPEUTICS, INC.
$86
Mayne Pharma Inc.
$84
TARO PHARMACEUTICALS USA, INC.
$79
Encore Dermatology Inc.
$48
Novum Pharma, LLC
$26
Taro Pharmaceuticals USA, Inc.
$23
Almirall LLC
$17
Aclaris Therapeutics, Inc.
$17
Mission Pharmacal Company
$17
Top 3 companies account for 69.2% of all-time payments
Associated products mentioned in payments ›
ABSORICA LD · ADBRY · AKLIEF · AMZEEQ · ARAZLO · Alcortin A · Avar · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Clindacin ETZ · Cloderm Cream · DAXXIFY · DORYX · DUOBRII · DUPIXENT · ENSTILAR · EPSOLAY · EUCRISA · Enbrel · Exelderm · Genadur · HALOG · HALOG (Halcinonide Cream · HUMIRA · Halog · Humira · ILUMYA · Ilumya · Impoyz · JUBLIA · Neo-Synalar · Neo-Synalar Cream · Neo-Synalar Cream Kit · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · STELARA · Sernivo Spray · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · Targadox · Trianex · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · WYNZORA · Winlevi · XEOMIN · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a dermatology specialist in Chicago?
Compare dermatologists in the Chicago area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists in nearby ZIP areas
374
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
SWEDISH HOSPITAL
3.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Del Campo is a clinical cardiology specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Del Campo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Del Campo performed 338 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Del Campo receive payments from pharmaceutical companies?
Yes. Dr. Del Campo received a total of $60,542 from 40 companies across 918 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Del Campo's costs compare to other dermatologists in Chicago?
Dr. Del Campo's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Del Campo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →